We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$735M
AUM Growth
+$91.2M
Cap. Flow
+$63.4M
Cap. Flow %
8.63%
Top 10 Hldgs %
24.07%
Holding
118
New
17
Increased
44
Reduced
5
Closed
14

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$14.4M
2
SYNA icon
Synaptics
SYNA
+$9.97M
3
DATA
Tableau Software, Inc.
DATA
+$9.41M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.8M
5
AKBA icon
Akebia Therapeutics
AKBA
+$4M

Top Sells

Rank Stock Value
1
PBYI icon
Puma Biotechnology
PBYI
+$4.68M
2
SJM icon
J.M. Smucker
SJM
+$4.51M
3
NOV icon
NOV
NOV
+$3.7M
4
PCYC
PHARMACYCLICS INC
PCYC
+$2.7M
5
ECYT
Endocyte, Inc. Common Stock
ECYT
+$2.33M

Sector Composition

Rank Sector Weight
1 Healthcare 26.56%
2 Technology 14.37%
3 Consumer Discretionary 13.18%
4 Industrials 9.24%
5 Materials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYB icon
26
LyondellBasell Industries
LYB
$19.5B
$11.1M 1.51%
113,900
– –
UFS
27
DELISTED
DOMTAR CORPORATION (New)
UFS
$11.1M 1.51%
258,600
– –
PTLA
28
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$10.9M 1.48%
372,400
+8,900
+2% +$215K
DATA
29
DELISTED
Tableau Software, Inc.
DATA
$10.7M 1.46%
+150,100
New +$9.41M
ININ
30
DELISTED
Interactive Intelligence Group, inc.
ININ
$10.3M 1.41%
184,200
+13,300
+8% +$761K
CXP
31
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$10.2M 1.39%
393,800
+58,000
+17% +$1.58M
CCI icon
32
Crown Castle
CCI
$33.4B
$9.71M 1.32%
130,700
– –
ACAD icon
33
Acadia Pharmaceuticals
ACAD
$4.55B
$9.56M 1.3%
423,200
+229,700
+119% +$4.8M
VMW
34
DELISTED
VMware, Inc
VMW
$9.47M 1.29%
97,800
+19,200
+24% +$1.87M
NRG icon
35
NRG Energy
NRG
$28.3B
$9.43M 1.28%
253,400
+60,000
+31% +$2.07M
LGND icon
36
Ligand Pharmaceuticals
LGND
$5.94B
$9.32M 1.27%
239,969
+2,885
+1% +$117K
IPHI
37
DELISTED
INPHI CORPORATION
IPHI
$9.31M 1.27%
634,200
+30,900
+5% +$465K
CMRX
38
DELISTED
Chimerix, Inc.
CMRX
$9.18M 1.25%
418,600
+6,700
+2% +$133K
SDRL
39
DELISTED
Seadrill Limited Common Stock
SDRL
$9.17M 1.25%
857
+37
+5% +$361K
NVAX icon
40
Novavax
NVAX
$1.22B
$8.82M 1.2%
95,435
+8,390
+10% +$737K
ASML icon
41
ASML
ASML
$634B
$8.75M 1.19%
93,800
– –
CMRE icon
42
Costamare
CMRE
$1.87B
$8.4M 1.14%
360,200
– –
STML
43
DELISTED
Stemline Therapeutics, Inc.
STML
$8.21M 1.12%
559,800
+197,400
+54% +$3.03M
BWA icon
44
BorgWarner
BWA
$13.2B
$8.19M 1.11%
142,682
+14,768
+12% +$813K
OII icon
45
Oceaneering
OII
$4.74B
$8.12M 1.1%
103,900
– –
SRPT icon
46
Sarepta Therapeutics
SRPT
$1.64B
$7.72M 1.05%
259,100
– –
PCYC
47
DELISTED
PHARMACYCLICS INC
PCYC
$7.41M 1.01%
82,600
-28,800
-26% -$2.7M
NPSP
48
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$7.4M 1.01%
223,900
-60,000
-21% -$1.73M
SGMO
49
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$7.37M 1%
482,500
+20,000
+4% +$288K
AYR
50
DELISTED
Aircastle Ltd
AYR
$7.1M 0.97%
399,600
– –
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Eventide Asset Management held 118 positions worth $735M, up 14% from $644M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $63.4M of net new capital in Q2 2014, opening 17 new positions and adding to 44 existing holdings. Its largest new stake was Celgene Corp: 190,000 shares worth $16.3M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was PHARMACYCLICS INC, an estimated $2.7M trimmed.

  • Eventide Asset Management's largest Q2 2014 buy was Celgene Corp: 190,000 shares worth $16.3M.
  • Eventide Asset Management added most to Acadia Pharmaceuticals in Q2 2014, an estimated $4.8M increase.
  • Eventide Asset Management's biggest Q2 2014 reduction was PHARMACYCLICS INC, cutting an estimated $2.7M.
  • Eventide Asset Management fully exited Puma Biotechnology in Q2 2014, selling an estimated $4.68M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $735M portfolio in Q2 2014.
  • Eventide Asset Management opened 17 new positions and closed 14 in Q2 2014.
  • Eventide Asset Management's portfolio value rose 14% quarter-over-quarter to $735M.

Based on Eventide Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.